Epidemiology of Prostate Cancer
- PMID: 31068988
- PMCID: PMC6497009
- DOI: 10.14740/wjon1191
Epidemiology of Prostate Cancer
Abstract
Prostate cancer is the second most frequent cancer diagnosis made in men and the fifth leading cause of death worldwide. Prostate cancer may be asymptomatic at the early stage and often has an indolent course that may require only active surveillance. Based on GLOBOCAN 2018 estimates, 1,276,106 new cases of prostate cancer were reported worldwide in 2018, with higher prevalence in the developed countries. Differences in the incidence rates worldwide reflect differences in the use of diagnostic testing. Prostate cancer incidence and mortality rates are strongly related to the age with the highest incidence being seen in elderly men (> 65 years of age). African-American men have the highest incidence rates and more aggressive type of prostate cancer compared to White men. There is no evidence yet on how to prevent prostate cancer; however, it is possible to lower the risk by limiting high-fat foods, increasing the intake of vegetables and fruits and performing more exercise. Screening is highly recommended at age 45 for men with familial history and African-American men. Up-to-date statistics on prostate cancer occurrence and outcomes along with a better understanding of the etiology and causative risk factors are essential for the primary prevention of this disease.
Keywords: Epidemiology; Etiology; Incidence; Mortality; Prevention; Prostate cancer; Risk factors; Survival; Trends.
Conflict of interest statement
None of the authors have conflict of interest.
Figures
Similar articles
-
Prostate-Specific Antigen-Based Screening for Prostate Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May. Report No.: 17-05229-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May. Report No.: 17-05229-EF-1. PMID: 30085502 Free Books & Documents. Review.
-
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors.World J Oncol. 2019 Feb;10(1):10-27. doi: 10.14740/wjon1166. Epub 2019 Feb 26. World J Oncol. 2019. PMID: 30834048 Free PMC article. Review.
-
Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons.BJU Int. 2002 Jul;90(2):162-73. doi: 10.1046/j.1464-410x.2002.2822.x. BJU Int. 2002. PMID: 12081758 Review.
-
An In-Depth Look Into the Epidemiological and Etiological Aspects of Prostate Cancer: A Literature Review.Cureus. 2023 Nov 4;15(11):e48252. doi: 10.7759/cureus.48252. eCollection 2023 Nov. Cureus. 2023. PMID: 38054148 Free PMC article. Review.
-
Italian cancer figures, report 2012: Cancer in children and adolescents.Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. Epidemiol Prev. 2013. PMID: 23585445 English, Italian.
Cited by
-
Caffeic acid hinders the proliferation and migration through inhibition of IL-6 mediated JAK-STAT-3 signaling axis in human prostate cancer.Oncol Res. 2024 Nov 13;32(12):1881-1890. doi: 10.32604/or.2024.048007. eCollection 2024. Oncol Res. 2024. PMID: 39574470 Free PMC article.
-
Trend in incidence and clinicopathological characteristics of prostate cancer in Northern Tanzania: analysis from a population based cancer registry data 2015-2021.BMC Cancer. 2024 Nov 19;24(1):1424. doi: 10.1186/s12885-024-13194-6. BMC Cancer. 2024. PMID: 39563287 Free PMC article.
-
Anticancer potential of phytochemicals derived from mangrove plants: Comprehensive mechanistic insights.Food Sci Nutr. 2024 Jul 10;12(9):6174-6205. doi: 10.1002/fsn3.4318. eCollection 2024 Sep. Food Sci Nutr. 2024. PMID: 39554337 Free PMC article. Review.
-
NRG1 secreted by cancer-associated fibroblasts contributes to enzalutamide resistance in prostate cancer cells.Am J Cancer Res. 2024 Oct 15;14(10):4830-4840. doi: 10.62347/OTTR3398. eCollection 2024. Am J Cancer Res. 2024. PMID: 39553203 Free PMC article.
-
Integrated proteomics and metabolomics analyses reveal new insights into the antitumor effects of valproic acid plus simvastatin combination in a prostate cancer xenograft model associated with downmodulation of YAP/TAZ signaling.Cancer Cell Int. 2024 Nov 16;24(1):381. doi: 10.1186/s12935-024-03573-1. Cancer Cell Int. 2024. PMID: 39550583 Free PMC article.
References
-
- Ferlay J EM, Lam F, Colombet M, Mery L, Pineros M, Znaor A, Soerjomataram I. et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, Accessed 02 February 2019. [Internet]
-
- Ferlay J EM, Lam F, Colombet M, Mery L, Pineros M, Znaor A, Soerjomataram I. et al. Global cancer observatory: cancer tomorrow. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/tomorrow, Accessed 02 February 2019. [Internet]
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources